Use of the tumour suppressor gene p33ing1 for modulation of p53 activity and in tumour diagnosis
CA 2305809 A1 · Owner: Board Of Trustees Of The University Of Illinois · Inventors: Gudkov, Andrei; Riabowol, Karl; Garkavtsev, Igor
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention relates to a method for modulating the activity of the protein p53 in cells by the addition of a peptide or protein having p33ING1 biological activity or a nucleic acid coding for such a peptide or protein.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 24, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 24, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 24, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.